These studies have indicated that repeated doses of anti-VEGF medications, such as ranibizumab, may prevent blood vessels from leaking fluid and causing macular edema.
If left untreated, about a quarter of people with diabetes eventually lose some of their vision from diabetic macularedema — a condition in which leaking blood vessels cause swelling in the center of the retina.